These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 16428244)

  • 1. The clinical and economic benefits of capecitabine and tegafur with uracil in metastatic colorectal cancer.
    Almond J; Ralston S
    Br J Cancer; 2007 May; 96(9):1489; author reply 1490. PubMed ID: 17437019
    [No Abstract]   [Full Text] [Related]  

  • 2. A pilot study: dose adaptation of capecitabine using mobile phone toxicity monitoring - supporting patients in their homes.
    Weaver A; Love SB; Larsen M; Shanyinde M; Waters R; Grainger L; Shearwood V; Brooks C; Gibson O; Young AM; Tarassenko L
    Support Care Cancer; 2014 Oct; 22(10):2677-85. PubMed ID: 24771299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inappropriate continuation of medication when patients are admitted acutely: the example of capecitabine.
    Booth JA; Booth C; Crawford SM
    Clin Med (Lond); 2011 Oct; 11(5):511. PubMed ID: 22034726
    [No Abstract]   [Full Text] [Related]  

  • 4. A valid formulation of the analysis of noninferiority trials under random effects meta-analysis.
    Brittain EH; Fay MP; Follmann DA
    Biostatistics; 2012 Sep; 13(4):637-49. PubMed ID: 22467938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of biodegradable nanoparticles for oral delivery of doxorubicin: in vivo pharmacokinetics and toxicity studies in rats.
    Kalaria DR; Sharma G; Beniwal V; Ravi Kumar MN
    Pharm Res; 2009 Mar; 26(3):492-501. PubMed ID: 18998202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of advanced colorectal cancer: state of the art.
    Saunders M; Iveson T
    Br J Cancer; 2006 Jul; 95(2):131-8. PubMed ID: 16835584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral versus intravenous fluoropyrimidines for advanced colorectal cancer: by either route, it's all the same.
    Mayer RJ
    J Clin Oncol; 2001 Nov; 19(21):4093-6. PubMed ID: 11689576
    [No Abstract]   [Full Text] [Related]  

  • 8. A randomised cross-over trial comparing patient preference for oral capecitabine and 5-fluorouracil/leucovorin regimens in patients with advanced colorectal cancer.
    Twelves C; Gollins S; Grieve R; Samuel L
    Ann Oncol; 2006 Feb; 17(2):239-45. PubMed ID: 16344278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-line capecitabine is as effective as 5-fluorouracil/leucovorin in treating advanced colorectal cancer.
    Gambill BD
    Clin Colorectal Cancer; 2001 May; 1(1):18-9. PubMed ID: 12445375
    [No Abstract]   [Full Text] [Related]  

  • 10. [Capecitabine in colorectal carcinoma: news from ASCO 2008]].
    Longo F; Mansueto G
    Tumori; 2008; 94(4):suppl 15-23. PubMed ID: 18822712
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of adjuvant capecitabine compared with bolus 5-fluorouracil/leucovorin regimen in dukes C colon cancer: results from the X-ACT trial.
    Reddy GK
    Clin Colorectal Cancer; 2004 Jul; 4(2):87-8. PubMed ID: 15285814
    [No Abstract]   [Full Text] [Related]  

  • 12. On prejudice and facts and choices.
    Köhne CH; Folprecht G
    Ann Oncol; 2006 Feb; 17(2):185-7. PubMed ID: 16428244
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.